Today: 9 June 2026
OCBC stock rises as new securities-financing push puts fee income in focus
22 January 2026
1 min read

OCBC stock rises as new securities-financing push puts fee income in focus

Singapore, Jan 22, 2026, 15:03 SGT — Regular session

  • OCBC shares rose during Singapore’s afternoon trading session.
  • The bank has rolled out a securities financing unit aimed specifically at institutional clients.
  • A filing showed treasury shares had been earmarked for employee programs.

OCBC shares rose Thursday as investors showed fresh enthusiasm for the bank’s growing securities financing division, a key source of fee income and trading revenues. The stock nudged higher to S$20.56 from Wednesday’s close of S$20.44.

The move stands out as a straightforward bet on non-interest income, especially since bank stocks have mostly peaked. Investors are looking for evidence that growth isn’t just about lending, given how clients shift collateral amid market turbulence.

Singapore’s Straits Times Index slipped 0.4% in the last session, with the three local banks closing mixed, according to a market wrap.

OCBC has launched a new Securities Financing Unit inside its global markets division. According to a statement, the unit will offer lending options based on securities held in client accounts across OCBC and its subsidiaries, such as OCBC Securities, Bank of Singapore, and Great Eastern.

Securities financing spans various activities. It includes lending cash backed by equities or bonds, plus securities lending—loaning out shares or fixed income instruments for a fee. This practice often supports short positions or meets collateral demands, letting the lender earn the spread.

“Access to liquidity and efficient capital deployment have become crucial,” said Kenneth Lai, OCBC’s head of global markets, pointing to a spike in demand from institutional clients. The bank also flagged a record US$15.3 billion in global securities-lending revenues forecast for 2025, based on EquiLend Data & Analytics. theasianbanker.com

A separate filing showed OCBC used 184,470 treasury shares on Jan. 21 for employee share schemes, cutting its treasury share count to 10,826,386. The stated value is about S$2.76 million.

Traders are focused on whether the new unit delivers beyond a well-crafted press release. Any meaningful uptick in customer activity or fee income likely won’t show up immediately. The bank has yet to share any revenue projections.

But the business faces its hurdles. Securities financing swings with changes in risk appetite and market turnover, while global banks are fiercely competing for the same institutional flow in the region. A sharp drop in trading or a rapid risk-off move can send volumes plummeting.

OCBC is set to unveil its full-year 2025 earnings on Feb. 25, before the market opens. This will be a crucial date for investors to watch.

Stock Market Today

  • U.S. Inflation Poised to Exceed 4% for First Time Since 2023, Pressures Mount on Fed
    June 9, 2026, 10:06 AM EDT. U.S. inflation is set to surpass 4% for the first time since 2023, signaling rising consumer prices and intensifying economic pressures. This uptick, measured by the year-over-year increase in the Consumer Price Index (CPI), highlights renewed challenges for the Federal Reserve (Fed) as it grapples with balancing inflation control against economic growth. The rise in inflation may influence the Fed's monetary policy decisions amid concerns over sustained price increases impacting households and businesses for the remainder of the year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD
Previous Story

Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update
Next Story

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update

Go toTop